Westermann, A M <br/><br/>
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.  [electronic resource] 

 -  Oncology  2003 
 - 312-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000070287  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carboplatin--administration & dosage<br/>Combined Modality Therapy<br/>Etoposide--administration & dosage<br/>Female<br/>Filgrastim<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Hyperthermia, Induced<br/>Ifosfamide--administration & dosage<br/>Lenograstim<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--therapeutic use<br/>Sarcoma--drug therapy<br/>Survival Analysis<br/>Treatment Outcome